Advanced Therapies Congress

Advanced Therapies UK 2027 / Advanced Therapies Congress is Europe's largest commercial cell and gene therapy conference and exhibition, taking place on 9-10 March 2027 at ExCeL London. The event is for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest technology and strategies driving the industry forward. It brings together a community of 3,300 global executives, with 300+ speakers, 200+ exhibitors and 75+ biotech start-ups over 2 days. The programme features speakers from across the entire value chain of cell and gene therapy development, including pharma, biotech and start-up companies, researchers, clinicians, academics, HTAs, payers and regulators. The conference includes 8 tracks of content, while the exhibition brings together 50 leading solution providers across all stages of cell and gene therapy development. Attendees can also access 12+ hours of built-in 1-2-1 networking. Content themes cover clinical success, regulatory challenges, reimbursement and market access, cross-border healthcare, outcome-based agreements, autologous vs allogeneic therapies, solid tumours, combination therapy, CAR-T, NK and gamma-delta cells, stem cells, regenerative medicine, gene therapy, immunogenicity, novel gene delivery systems, automation, closed systems, scaling up, continuous manufacturing, logistics, cold chain, supply chain, point-of-care delivery, patient pathways, accessibility, academic research, cutting-edge technology, safety and ethics, AI in oncology, precision medicine, investor perspectives and start-up presentations.